Belgian drugmaker Galapagos NV has named former Johnson & Johnson senior executive Paul Stoffels as its CEO, effective from April 1, 2022. Since 2012, Stoffels was the chief scientific officer at Johnson & Johnson and has spearheaded the development of its single-shot… Read More ›
Late of Sunday, Emergent BioSolutions Inc said, a key U.S. agency has increased an order related to the manufacturing of Johnson & Johnson’s COVID-19 vaccine, by $23 million. “The amount will be used to purchase biologics equipment specific to J&J’s… Read More ›
In a statement, Brazil’s health ministry said, it will be signing a non-binding letters of intent to buy coronavirus vaccines from four companies as well as from Russia’s sovereign wealth fund; these purchases will be subject to the approval of… Read More ›
In a statement, Saudi Aramco said, it has appointed Mark Weinberger to its board of directors as an independent director. Weinberger will replace Andrew Gould, said the company in a statement. Weinberger was the global Chairman and CEO of EY (previously… Read More ›
If the development has cascading effect and more retailers pull J&J’s baby talc powder from shelves, it could significantly impact its earnings. Already J&J is facing lawsuits over allegations of asbestos in its talc. Following U.S. healthcare conglomerate Johnson &… Read More ›
Johnson & Johnson expects an increase in demand for its cancer drugs. On Tuesday, Johnson & Johnson first quarterly report beat analysts’ estimate and raised its full-year sales forecast on the strength of a growing demand for its cancer drugs…. Read More ›
The verdict piles on top of 3 previous verdicts which have acquitted the drugmakers in lawsuits related to the drug Xarelto. The ruling could add as a precedent to the 21,400 lawsuits that J&J is facing in federal and state… Read More ›
Of late Johnson & Johnson has been very active in the M&A sector. A significant portion of its earnings have been derived from acquired products. Bloomberg has reported citing sources familiar with the matter at hand, that Johnson & Johnson… Read More ›
manageria.biz 